Kernal Biologics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
47
Kernal Biologics General Information
Description
Developer of onco-selective mRNA therapeutics designed to program human cells directly inside the body. The company utilizes a machine learning-backed computational pipeline to discover cell-specific sequence features and proprietary decorated lipid nanoparticles for targeted extrahepatic delivery, enabling the healthcare sector to access scalable in vivo cell therapies that maximize treatment efficacy while minimizing off-target toxicity.
Contact Information
Website
www.kernalbio.comCorporate Office
- 238 Main Street
- Cambridge, MA 02142
- United States
Corporate Office
- 238 Main Street
- Cambridge, MA 02142
- United States
Kernal Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 26-Aug-2025 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC (Series A1) | 07-Apr-2025 | Completed | Pre-Clinical Trials | |||
| 5. Later Stage VC (Series A) | 07-Jul-2022 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 21-Oct-2020 | Completed | Startup | |||
| 3. Accelerator/Incubator | 26-Aug-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 18-Oct-2018 | $500K | $500K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Kernal Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | 5,406,319 | $0.000100 | $0.59 | $0.59 | 1x | $0.59 | 15.73% | |
| Seed-2 | 1,785,184 | $0.000100 | $0.08 | $0.08 | 1x | $0.08 | 5.19% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Kernal Biologics Comparisons
Industry
Financing
Details
Kernal Biologics Competitors (2)
One of Kernal Biologics’s 2 competitors is Sirnaomics, a Formerly VC-backed company based in Gaithersburg, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sirnaomics | Formerly VC-backed | Gaithersburg, MD | ||||
| TransCode Therapeutics | Formerly VC-backed | Boston, MA |
Kernal Biologics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kernal Biologics Patents
Kernal Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026035680-A1 | Compositions and methods for delivery of agents | Pending | 06-Aug-2024 | ||
| EP-4739652-A1 | Lipids and compositions thereof | Pending | 03-Jul-2023 | ||
| US-20260116845-A1 | Lipids and compositions thereof | Pending | 03-Jul-2023 | ||
| WO-2025010290-A1 | Lipids and compositions thereof | Inactive | 03-Jul-2023 | ||
| EP-4709864-A1 | Oncoselective therapy | Pending | 10-May-2023 | C07K14/5443 |
Kernal Biologics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kernal Biologics Investors (47)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Amino Collective | Venture Capital | Minority | ||
| Astir Ventures | Venture Capital | Minority | ||
| BlueLotus Ventures | Venture Capital | Minority | ||
| DO Venture Partners | Venture Capital | Minority |
Kernal Biologics FAQs
-
When was Kernal Biologics founded?
Kernal Biologics was founded in 2016.
-
Where is Kernal Biologics headquartered?
Kernal Biologics is headquartered in Cambridge, MA.
-
What is the size of Kernal Biologics?
Kernal Biologics has 21 total employees.
-
What industry is Kernal Biologics in?
Kernal Biologics’s primary industry is Drug Discovery.
-
Is Kernal Biologics a private or public company?
Kernal Biologics is a Private company.
-
What is Kernal Biologics’s current revenue?
The current revenue for Kernal Biologics is .
-
How much funding has Kernal Biologics raised over time?
Kernal Biologics has raised $36.1M.
-
Who are Kernal Biologics’s investors?
Amgen Ventures, Amino Collective, Astir Ventures, BlueLotus Ventures, and DO Venture Partners are 5 of 47 investors who have invested in Kernal Biologics.
-
Who are Kernal Biologics’s competitors?
Sirnaomics and TransCode Therapeutics are competitors of Kernal Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
